Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
Perspective Therapeutics to Participate at Upcoming May Investor[...]
04/18/2024 | Press release | Distributed by Public on 04/18/2024 08:03
Please select the service you want to use:
Smartlinks | Grifols SA | News | Health | Finance | Security Markets | Security Markets | Company News | Company Appointments | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | OTC Markets | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Madrid Stock Exchange (MAD) | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Aquis Exchange | SIGMA X MTF | Bolsa Institucional de Valores (BIVA) | Equiduct | Euronext Block MTF | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact